https://pubchem.ncbi.nlm.nih.gov/patent/US-2014186829-A1
Method for predicting insulinopenic type 2 diabetes - Patent US-2014186829-A1 - PubChem
US-2014186829-A1 chemical patent summary.
https://pubmed.ncbi.nlm.nih.gov/19227471/?fbclid=IwAR0jkN_2Ir0K6B-WKUwSdnLtvFkIHC31sZb_T31G1TbRDERej-qiN8ab9dE
Effects of proinsulin C-peptide on oxygen transport, uptake and utilization in insulinopenic...
Exogenous C-peptide administration has beneficial effects in many of the tissues commonly affected by diabetic complications. Diabetes-induced circulatory...